Nghĩa của từ T cell non antigen specific suppressor factor bằng Tiếng Việt
danh từ
yếu tố tế bào T ức chế không đặc hiệu kháng nguyê
Đặt câu có từ "T cell non antigen specific suppressor factor"
1. Cell mediated immune response (CMI) is the host defense that are mediated by Antigen specific T-cells and various non-specific cells of immune system
2. T-Cell Clonality; T cell antigen receptors, Gene Rearrangement; Laboratory
3. An Antigen-specific B cell antibody specifically recognizes a TI-2 Antigen, but without T cell help, a memory response is not seen.
4. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which Afferently regulates DTH responses
5. Chimeric Antigen Receptor (CAR) T-cell Therapy
6. Upon contact with its specific antigen, the T cell receptor transduces an activation signal into the T cell, leading to proliferation, cytokine production, or efficient cytotoxicity.
7. Adoptive T-cell therapies with T-cells modified with chimeric antigen receptors (CAR-T) also causes CRS.
Điều trị miễn dịch ung thư bằng tế bào T đã được sửa đổi có các thụ thể kháng nguyên chimeric (CAR-T) cũng gây ra CRS.
8. At the same time, carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC) and tumor specific growth factor (TSGF) were also measured by microparticle enzyme immune analysis, bio-antibody sandwich, and chemo-Chromatometry.
9. As with B cells, each type of T cell recognizes a different antigen.
Giống như các tế bào B, mỗi loại tế bào T nhận ra một kháng nguyên khác nhau.
10. Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
11. Adjuvant also protects the antigen through non-specific stimulation of immune response.
12. Through production of these cytokines, iNKT cells control adipose Treg and other T cell survival, proliferation and suppressor functions.
13. Cell surface expression vector for liver cancer specific antigen alpha-fetoprotein and microorganism transformed by thereof
14. Drug containing antibodies for treatment of t cell specific immune reactions and t cells leukemias
15. Enhancements in the Cytotoxic activity of tumor antigen-specific Cytotoxic T cells in the tumor microenvironment are
16. Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell
17. T cell Clonality testing has important clinical and research value, providing a specific and reproducible assessment of clonal diversity in T cell proliferations
18. The Company develops Allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors.
19. T cell Clonality testing has important clinical and research value, providing a specific and reproducible assessment of clonal diversity in T cell proliferations
20. The delivery of the second signal by the antigen-presenting cell rescues the activated T cell from Anergy, allowing it to produce the lymphokines
21. Again, inhibition of suppressor cell activity was postulated to be responsible.
22. Specific and persistent activation of heat shock response in cell lines using a viral factor
23. Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment. In this strategy, a patient's own T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen.
24. The antibody ACSA-1 (Astrocyte cell surface antigen-1) recognizes an extracellular epitope of the Astrocyte specific transmembrane glycoprotein GLAST
25. For Cell mediated rejection, T cells require multiple signals for activation, the minimum being two signals; antigen recognition and costimulation